Together this data suggests a temporally and spatially regulated role of CD46 in adaptive immune responses, which also serves as an important indication that the complement cascade is capable of exerting a driving influence on adaptive T cell responses during anti-tumor responses. The gene discussed is CD46; the disease is neoplasm.